Member Log-in

I forgot my password

Not a Member? Register

New Guide Helps Countries Assess Immunization Financing Options

Helen Saxenian, Cheryl Cashin, and Paul Wilson, Results for Development

Maintaining high rates of immunization coverage, which is essential for a persistent reduction in the incidence of vaccine-preventable infectious diseases, requires a sufficient and sustained investment. In order to ensure that governments are making adequate investments in immunization financing and are doing so through sustainable policies, advocates and policymakers must be equipped with up-to-date information regarding the full array of policy options, strategies, and challenges of innovative immunization financing.

A new resource guide—funded by the Bill & Melinda Gates Foundation and developed by Results for Development—seeks to provide this information in a single source.

Immunization Financing: A Resource Guide for Advocates, Policymakers, and Program Managers was formally released on February 21, 2017. The guide is an update to the Immunization Financing Toolkit: A Resource for Policy-Makers and Program Managers, published by the World Bank and the Gavi Alliance in December 2010. Since the publication of the toolkit in 2010, several important trends have emerged, including new vaccines added to national schedules, increased country transitions from Gavi support, and growing commitments to immunization financing and universal health coverage.

The new guide is comprised of 26 briefs, with eight country case studies, and is intended for both Gavi and non-Gavi eligible countries. Copies are available for download at French, Spanish, and Russian translations of the guide are available on the website as well.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Practitioner Perspectives: Tbilisi Vaccine Procurement Workshop Interview Series – Dilorom Tursunova (1 of 4)

During our regional vaccine procurement workshop, which took place in Tbilisi, Georgia in April 2019, we sat down with a few participants to hear about their experiences related to topics ranging from vaccine forecasting, vaccine budgeting, and vaccine regulatory issues. This interview (first in a series of 4) is with Dilorom Tursunova, Deputy Chief of the … Continued

Choose a Language